Evaluation of cerebrospinal fluid phosphorylated tau(231) as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia

BACKGROUND: The diagnosis of either Alzheimer's disease (AD) or vascular dementia (VaD) is still largely based on clinical guidelines and exclusion of other diseases that may lead to dementia. AIMS: In this study, we assessed whether the use of sensitive and specific biomarkers such as phosphor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Kiđemet‐Piskač, Spomenka, Babić Leko, Mirjana, Blažeković, Antonela, Langer Horvat, Lea, Klepac, Nataša, Sonicki, Zdenko, Kolenc, Danijela, Hof, Patrick R., Boban, Marina, Mimica, Ninoslav, Borovečki, Fran, Šimić, Goran
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047904/
https://ncbi.nlm.nih.gov/pubmed/29453935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12814
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados